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Objectives. This study was designed to t hypothesis that
Wg4tm oral supplemental of die L-a e (to provide a
sustalned eleva of nitric oxide activity) Id inhibit athero-
ger s In by eroletnic rabbits, as
by histomor-
measurements.
Background. End lium-derived nitric oxide Inhibits a num-
ber of that are critical In a s
. Hypercholes-
t red endothelial nitric oxide activity, and we
late that this y a
reduction in nitric
activity can be revs acutely by intravenous i of
L .,
the precursor of nitric oxide . We show that dietary
so tatlim of L abrogates the development of cor-
onary hype rolemic rabbits.
M . Male New
Zealand White rabbits were fed normal
rabbit chow, 1 % cholesterol chow or 1 % cholesterol chow with
d ine or methioniie supplementation to increase their
Intake of these amino acids sixfold. After 1 or 10 weeks of dietary
intervention, the left train and left anterior descending coronary
arteries were harvested for histologic study. Plasma cholesterol
measurements were elevated to the same degree in all groups of
Endothelium-derived relaxing factor is a potent endogenous
vasodilator, released from the endothelium in response to a
number of hemodynamic or humoral stimuli. This substance
has the characteristics of a nitrovasodilator and is nitric
oxide or a closely related molecule (1-3) . Nitric oxide is
derived from the metabolism of L-arginine to L-citrulline by
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rabbits receiving the 1 % cholesterol diet, whereas piss a arginine
levels were doubled in the inine-treat group. High density
0 rotein ( L) cholesterol values were not ected by arginine
treatment.
Results. In rabbits receiving the 1 cholesterol diet, with or
without methionine supplementation, light and electron micros-
copy revealed a marked increase from 1 to 10 weeks in the intinral
accumulation of macrophages, associated with an increase in the
int a of the left main coronary retry. By contrast, in
. de-treated hypercholesterolemic rabbits, there was a near
absence of adherent monocytes and tissue macrophages and no
progression of inti thickness from 1 to 10 weeks .
Conclusions. Dietary
supplements of L-arginine prevent ind-
thickening in the coronary arteries of by rcholestcrolemic
rabbits . This antiathe enic effect is not due to an alteration in
plasma total cholesterol, HDL cholesterol or caloric or nitrogen
balance . The data are consistent with the hypothesis that nitric
oxide has antiathe epic properties.
(J Am Loll Cardiol 1994,23 .452-8)
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nitric oxide synthase, which has recently been cloned and
characterized (4-6) . In addition to its effects on vasomotion,
nitric oxide inhibits monocyte adherence and chemotaxis
(7), platelet adherence and aggregation (8-10) and vascular
smooth muscle proliferation (11) . Because these processes
are critically involved in atherogenesis, we postulate that
nitric oxide is an antiatherogenic molecule .
Wa and others (12-18) have shown that in animals and
humans, hypercholesterolemia inhibits nitric oxide-
dependent vasodilation. We (16-18) recently demonstrated
that this abnormality can be reversed acutely by administer-
ing large intravenous doses of L-arginine, the precursor of
nitric oxide . We subsequently found that long-term oral
administration of L-arginine induced a sustained elevation of
plasma arginine and a significant improvement in nitric
oxide-dependent vasodilation in hypercholesterolemic rab-
bits (19) . This effect occurred in the absence of any alteration
in plasma cholesterol. The sustained augmentation of nitric
oxide activity was associated with an antiatherogenic effect,
as manifested by a 50% to 75% reduction in the thickness
and surface area of intimal lesions in the descending thoracic
0735-1097/941$7 .00
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aorta (19) . We now report that supplements of dietary
L-arginine esseptially abolish the development of intimal
lesions in the left main coronary artery of hypercholester-
olemic rabbits .
Methods
Animals. Male New Zealand White rabbits were assigned
to one of three treatment groups : I I were fed normal rabbit
chow (control group) ; 10 received chow containing 1%
cholesterol ; I I received a 1% cholesterol diet supplemented
with 2.25% L-arginine hydrochloride in the drinking water
throughout the course of the study, and 6 received a 1%
cholesterol diet supplemented with 0.9% methionine hydro-
chloride in the drinking water . Normal rabbit chow contains
0.9% L-arginine and 0 .36% L-methionine by weight. Supple-
mentation with 2 .25% L-arginine Cr 0.9% L-Mthionine in
drinking water results in a sixfold increase in daily L-arginine
or L-Methionine intake, respectively (based on the average
water and food intake of the animals) . We previously
showed that this amount of L-arginine supplementation is
well tolerated and results in a twofold increase in plasma free
arginine levels (19) . Supplementation with a 1 .2% L-arginine
solution is also well tolerated but only increases plasma
arginine levels by 50% . Lower doses did not have a measur-
able effect on plasma arginine . Solutions of L-arginine
>2 .25% were not tolerated .
After I or 10 weeks of the dietary intervention, the rabbits
were ligntly sedated with a 3 .0-mg subcutaneous injection of
acepromazine maleate solution (Ayerst Laboratories), and
the central ear artery was cannulated for collection of blood
samples. Subsequently, the animals were killed with an
overdose of pentobarbital sodium, and the heart and ascend-
ing aorta were excised en bloc . Immediately thereafter, the
aorta was cannulated and perfused under pressure
(80 mm Hg) for I min with cold physiologic saline solution,
followed by phosphate-buffered formalin for 5 min . Subse-
quently, the left main and left anterior descending coronary
arteries were harvested for histologic study . The thoracic
aorta was harvested from a subset of the rabbits (n = 16) for
studies of vascular structure and reactivity (these data have
been reported separately [19]) . These protocols were ap-
proved by the Administrative Panel on Laboratory Animal
Care of Stanford University and were performed in accor-
dance with the recommendations of the American Associa-
tion for Accreditation of Laboratory Animal Care .
Biochemical studies. Before initiation of the diet, and
after I or 10 weeks of treatment, blood samples were
collected from rabbits in each group for measurement of
plasma free arginine and plasma cholesterol . Blood was
obtained by cannulation of the central ear artery and col-
lected into 10-ml glass vials containing potassium ethylene-
diaminetetraacetic acid . The sample was then centrifuged at
1,800 g for 10 min and the plasma supernatant collected. For
measurement of plasma arginine, plasma was deproteinized
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with 2% sulfosalicylic acid and analyzed for free arginine
using an automated amino acid analyzer (Beckman 6300), as
previously described (19). Plasma cholesterol measurements
were performed using a modification of the enzymatic
method of Allain et al . (20) developed by Sigma Diagnostics .
This assay utilizes cholesterol oxidase to generate hydrogen
peroxide, which is then coupled with a chromogen to yield a
quinoneimine dye with an absorbance maximum at 500 nm .
Elistologic studies . Electron microscopy . Morphologic
features of the endothelium were examined by transmission
and scanning electron microscopy . For scanning electron
microscopy, left anterior descending coronary artery seg-
ments were bisected longitudinally, dehydrated in graded
ethanol, critical point dried, sputter coated with gold and
examined with a IS140 scanning electron microscope . For
transmission electron microscopy, vascular segments were
placed in 2% glutaraldehyde, rinsed, postfixed in osmium
tetroxide, dehydrated and embedded in epoxy resin . Thin
sections stained with uranyl acetate and lead hydroxide were
examined with a Phillips 201 or Siemens IA electron micro-
scope .
Light microscopy . The entire left main coronary artery
of each rabbit was fixed in 10% buffered formalin and
embedded in paraffin . The left main coronary artery was
then sectioned throughout its length (six sections taken
every 500 tim) for a total of 24 to 36 cross sections/animal
and stained with the elastic van Gieson stain . Measurements
of intimal and medial areas of each cross section were made
by a skilled observer using an eyepiece grid with 100
counting points (line intersections), each 0 .4 mm apart
(21,22) . Total grid area (mm 2 ) was determined by measure-
ment of grid dimensions with a stage micrometer at the same
microscope magnification used for point counts . Total area
of the intima (or media) was defined as the number of grid
points overlying the intima (or media) . The area of each was
calculated by the formula 0TI(P) x grid area, where P is the
number of points counted over the intima (or media). All
cross sections from each left main coronary artery (24 to 36
cross sections) were analyzed and the values averaged to
give a single value for the intimal and medial cross-sectional
area for each vascular segment . In addition to intimal lesion
area, we determined the circumferential extent of the intimal
lesion or lesions by using the grid to measure the entire
circumference and that involved by any lesions . The circum-
ferential extent of the lesion or lesions is expressed as a
percent of the entire circumference .
Data analysis. Data are expressed as mean value ± SEM
.
Measurements of intimal and medial thickness, intima/media
ratios and circumferential extent were compared using inui-
tivariate analysis of variance of independent groups to
determine the overall difference, followed by a post hoc
Fisher test to determine statistical significance between
groups . Statistical significance was accepted at the 95%
significance level (p :s 0 .05) .
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TaMe 1. Biochemical Measurements
Tignificamly different from control value at the same time point, p < 0 .05 . Values presented are mean value ± SEM . Arg = rabbits receiving 1% cholesterol
diet supplemented with arginine ; Chol = rabbits receiving chow containing 1% cholesterol; Control = rabbits receiving normal chow
; HDL = high density
lipoprotein; Meth = rabbits receiving 1% cholesterol diet supplemented with methionine .
Results
Biochemical and hemodynamic measurements. After
I week, plasma cholesterol was significantly elevated in
rabbits receiving the 1% cholesterol diet (Table 1) . After 10
weeks of cholesterol feeding, the elevation in plasma cho-
lesterol was maintained (Table 1) in all groups receiving the
1% cholesterol diet .
Plasma arginine levels were doubled at I week in the
arginine-treated rabbits compared with levels in the control
group (Table 1) . Plasma arginine levels were not altered in
the hypercholesterolemic rabbits receiving L-methionine or
vehicle .
In a separate series of studies, we sought to determine
whether arginine treatment altered the level of high density
lipoprotein (HDL) cholesterol values . Rabbits were fed
normal chow (n = 6), a 1% cholesterol diet (n = 6) or a 1%
cholesterol diet supplemented with 2.25 1-7, arginipt in the
drinking water (n = 6) . After 10 weeks, blood was collected
and processed as previously described for plasma total choles-
terol and HDL cholesterol measurements. The total choles-
terol and HDL cholesterol in the arg'nine-treated cholesterol-
fed rabbits was not different from that in the vehicle-treated
cholesterol-fed rabbits (Table 1) .
%womawvOkommWetwric ants after I week of treat .
ment . Electron microscopy. Scanning electron microscopy
of the left anterior descending coronary artery and aorta
from rabbits receiving normal chow revealed an intact
endothelial lining with fusiform cells all ned in the direction
of blood flow, which is typical of normal endothelium . By
contrast, in both hypercholesterolemic groups, ocr, ~sional
monocytes were found to be adherent to the endothelium,
and occasional deformations of the endothelial surface were
Table 2 .
Histomorphometric Measurements of Left Main Coronary Artery
observed. Transmission electron microscopy revealed that
these deformations were due to small localized collections of
lipid-laden macrophages in the subendothelial space .
Light microscopy . In rabbits receiving normal chow, the
intimal area was not measurable . In both of the hyper-
cholesterolemic groups . rare superficial and localized intimal
lesions (fatty streaks) were observed in the aorta and left
main coronary artery . However, the cross-sectional areas of
the intima and media were not different from those of
animals receiving normal chow (Table 2) .
Histomorphometric measurements after 10 weeks of treat®
ment . Electron microscopy . In rabbits receiving normal
chow, there was no difference in the appearance of the left
anterior descending coronary artery endothelium compared
with that of animals killed at I week . In the left anterior
descending coronary arteries of hypercholesterolemic (cho-
lesterol-supplemented) rabbits, small endothelial ulcerations
were observed by scanning electron microscopy . Adherent
monocytes Were abundant (Fig . IA), some of them dome-
shaped with typical ruffled surfaces, others with a very
irregular mottled surface . These changes were most notable
near the ostia of branching vessels . Lipid-laden smooth
muscle cells and macrophages were observed within the in-
tima and subjacent media by transmission electron micros-
copy (Fig. M). In rabbits receiving supplemental arginine,
these changes were distinctly less pronounced . Only occa-
sional adherent monocytes and small localized collections of
macrophages in the subendothelial space were observed .
Light microscopy. In rabbits receiving normal chow, the
intimal area was not measurable . In the left main coronary
artery of the rabbits receiving supplemental cholesterol,
intimal lesions were observed; there was a significant in-
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'Significantly different from control and arginine-supplemented diet values at the same time period
. tPercent of circumference of the cross section involved
by lesions. Values presented are mean value ± SEM
. Abbreviations as in Table 1 .
Week I Week 10
Control Choi Arg Control Choi Arg Meth
Intimal area (JAM') 0 13 ± 6 6 ± 6 0 193 ± 108* 1 ± I 202 ± 73*
Medial area (,um2)
118 ± 19 184 ± 80 194 ± 8 87 ± 4 210 ± 33 127 ± 15 182 ± 23
Intimatinedia ratio 0 0.11 ± 0.05 0.01 ± 0 .01 0 0.83 ± 0.35* 0.003 ± 0.003 0 .99 ± 0.29*
Circumference (%)t 0 14 ± 6 .6 6 .6 ± 6 .6 0 46 ± le 1 .7 ± 1 .7 55 ± 15*
1 Week 10 Weeks
Control
(n = 3) Choi (n = 3) Arg (n = 3)
Control
(n = 5-6)
Chol
(n = 5-6)
Arg
(n = 5-6)
Meth
(n = 6)
Plasma cholesterol (mg/dl) 141 t 99 545 t 200* 428 t 247* 55 t 10 643 Q 687 ± %* S'S ± 1V
Plasma HDL cholesterol (mg/dl) 8.2 t 1 .3 8.1±1 .8 7 .1 ± 0 .4
Plasma arginine (mm) 0.13 t 0.02 0.11 t 0 .02 0 .24 t 0 .05* 0 .15 t 0.02 0.15 0.02 0 .24 ± 0 .04* 0.12 ± 0.02
JACC Vol . 23, No
. 2
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Figure 1 . A, Scanning electron micrograph of the left anterior
descending coronary artery 10 weeks after initiation of a 1%
cholesterol diet reveals monocytes adhering to the endothelium .
Monocyte adherence was markedly reduced in hypercholester-
olemic rabbits receiving supplemental arginine . B, Transmission
electron micrograph of the left anterior descending coronary artery
10 weeks after initiation of a 1% cholesterol diet reveals a lipid-laden
macrophage (arrow) arising from the subendothelial space through a
gap in the endothelial cell layer (asterisks) . Collections of lipid-laden
macrophages with endothelial deformation and microulceration
were prominent in hypercholesterolemic rabbits receiving vehicle
but not in those receiving arginine supplementation .
crease in intimal thickness compared with that of left main
coronary arteries harvested at I week in this group, indicat-
ing significant progression of disease (Table 2, Fig . 2). By
contrast, in left main coronary arteries from rabbits receiv-
ing supplemental arginine ., only superficial and localized
intimal lesions were observed . There was no increase in
intimal thickness or circumferential extent of the lesions
compared with that in left main coronary arteries harvested
from rabbits receiving supplemental arginine at I week .
Indeed, the intimal area and intimal/medial ratio were not
different from those in rabbits receiving normal chow
(Fig. 3) .
In the hypercholesterolemic rabbits receiving methionine
supplementation intimal lesions consisting of large collec-
tions of lipid-laden macrophages were observed . The intimal
area, intimallmedial ratio and circumference of the coronary
artery
lesions were not different from those of the vehicle-
treated hypercholesterolemic rabbits (Table 2, Fig . 2) .
Discussion
Andatheregenic effects of
L-21'ginille . The salient finding
of this study is that intimal lesions did not develop in the
coronary arteries of hyperc hole sterolemic rabbits receiving
L-arginine supplementation . This effect was not due to an
alteration by L-arginine in plasma total cholesterol or HDL
cholesterol. Furthermore, this effect was not mimicked by
dietary supplementations of an amino acid that is not metab-
olized by nitric oxide synthase . These findings are consistent
with the hypothesis that arginine is antiatherogenic . We
propose that this property of arginine is due to its conversion
to nitric oxide .
L-Arginine is the primary prc cursor of nitric oxide (4) . In
previous studies we have found that the attenuation by
hypercholesterolemia of nitric oxide-dependent vasodila-
tion can be acutely reversed by administration of this pre-
cursor but not its inactive enantiomer D-aiginine (16-18,23) .
In hypercholesterolemic rabbits, endothelium-dependent
vasoddation of the thoracic aorta and hind limb resistance
vow els is improved by intravenous infusion of 1-arginine
(16,17). Endothelium-dependent vasodilation of forearm re-
sistance vessels in hypercholesterolemicc humans is also
normalized by intravenous administration of 1-arginine (18) .
The reversibility by arginine of the endothelial dysfunction
induced by hypercholesterolemia has now been confirmed
by other investigators (24-26) .
These findings led us to hypothesize that long-term
dietary supplementation of arginine would induce a sus-
tained improvement in nitric oxide-dependent vasodilation .
We further postulated that this long-term augmentation of
nitric oxide activity would retard atherogenesis . Indeed, we
discovered that a sixfold enrichment of dietary arginine
doubled plasma arginine levels, did not affect plasma cho-
lesterol values and improved nitric oxide-dependent vaso-
dilation in the descending thoracic aorta of hypercholester-
olemic rabbits (19) . These effects are associated with a
significant reduction in the extent ant, thickness of intimal
lesions in the thoracic aorta.
We now report that there is a virtual absence of lesions in
the coronary arteries of arginine-treated
hypercholester-
olemic rabbits . Arginine is at least as potent an antiathero-
WANG ET AL
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Figure
2. Photomicrographs of representative cross sections from the
left main coronary arteries of rabbits treated with vehicle (A),
supplemental methionine (B) and supplemental arginine (C) after 10
weeks on a 1% cholesterol diet
. There is a striking absence of intimal
lesions in the coronary arteries of the rabbits given supplemental
arginine . All photomicrographs were taken at a magnification of x 100.
Figure 3. Bar graph of intimalmedia ratios of the left main coro-
nary artery after I or 10 weeks of treatment in two groups of
hypercholesterolemic rabbits : those given vehicle (CHOL) and
those given supplemental arginine (ARG) . Values shown are
mean * SEM (vertical bars) . *Significantly different from all groups,
p < 0
.05 .
I week
CHOL
10
woo*
I weak
10 weak$
ARG
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genic agent in hypercholesterolemic rabbits as calcium chan-
nel antagonists, converting enzyme inhibitors or propranolol
(27-29). We now show that this effect of arginine is not
mimicked by another L-amino acid, nor is it associated with
changes in total or HDL cholesterol . Previously it has been
hypothesized that increases in dietary arginine may exert an
antiatherogenic effect by virtue of favorab!e alterations in
the lipoprotein profile (30), but this explanation seems un-
likely in view of the present data .
Role of nitric oxide. We have proposed that arginine
enhances the synthesis and release of endothelium-derived
nitric oxide from the hypercholesterolemic vessel, overcom-
ing an increased degradation (31) or reduced synthesis (32),
or both, induced by hypercholesterolemia. An increased
release of nitric oxide from the endothelium may inhibit
atherogenesis by limiting interactions of circulating blood
elements with the vessel wall . Indeed, monocyte adherence
to endothelial cells in culture, and chemotaxis in response to
formyl-methionyl-leucine-phenylalanine, is inhibited by
agents that release nitric oxide (7) . This effect on adherence
and chemotaxis may be mediated through effects on the
expression of adhesion molecules. Indeed, nitric oxide ap-
pears to modulate the expression of CD11/18 by neutrophils .
JACC Vol. 23, No . 2
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In the perfused rat mesenteric venule, N-methyl-arginine (a
nitric oxide synthase antagonist) increases the adhesion of
neutrophils to the endothelium by an order of magnitude, an
effect that is fully blocked by administration of arginine (33 .
The effect of N-methyl-arginine is associated with upregula-
tion of CEM 1/18, as assessed by flow cytometry (33) .
The effect of nitric oxide on the expression of this
adhesion molecule may explain the beneficial effect of nitro-
vasodilators in reperfusion injury . In reperfusion injury,
neutrophil adhesion and infiltration occur after flow is re-
stored to the experimentally occluded coronary artery . This
leukocyte-endothelial cell interaction is inhibited by an
infusion of sodium nitrite (34). Intracoronary infusion of
arginine has the same protective effect, which appears to be
due to its metabolism to nitric oxide because the effect is
blocked by nitric oxide synthase antagonists (35) . Thus, it is
possible that inhibition by nitric oxide of leukocyte-
endothelial cell interaction is involved in the antiatherogenic
effect of arginine . In addition, the antiplatelet effects ofnitric
oxide (8-10) and its ability to suppress vascular smooth
muscle growth (11) may contribute to the salutary effects of
arginine. Finally, there is preliminary evidence that nitric
oxide may interfere with the oxidation of low density
lipoprotein cholesterol by macrophages in cell culture (36).
Clinical relevance. Studies in our laboratory are under
way to determine the mechanism or mechanisms of the
antiatherogenic effect of L-arginine and to determine
whether the findings are relevant to humans . The short-term
response to arginine supplementation in hypercholester-
olemic humans is similar to that of our animal model
(16-18,23,26), so it is not unreasonable to anticipate anti-
atherogenic effects of dietary arginine supplementation in
humans . Indeed, there is indirect support for this hypothe-
sis. A recent epidemiologic study reveals that coronary
artery disease is reduced in heavy consumers of nuts and
legumes (37,38), food items that are rich in arginine (39) .
Conclusions . We find that dietary arginine supplementa-
tion inhibits the development of atherosclerotic lesions in the
aorta and coronary arteries of the hypercholesterolemic
rabbit . This effect is most pronounced in the coronary
arteries, where progression of disease was essentially abol-
ished. These effects are not due to changes in caloric or
nitrogen balance or plasma cholesterol . The effects of argi-
nine may be exerted through its metabolism to nitric oxide .
Further studies of the mechanism of this antiatherogenic
effect and its relevance to human disease are warranted,
given the potential ramifications that these findings may have
on public health and nutrition .
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